Danaher Corporation
Volume 173 · 173 F.T.C. 991
Cite this decision
Danaher Corporation, 173 F.T.C. 991 (2022). Consumer Law Library, https://consumerlawlibrary.org/decisions/v173-0025
Report an error in this record (decision id v173-0025)
Cited by 0 later FTC decisions
Cites
Text (OCR of the scan at left; may contain errors)
IN THE MATTER OF DANAHER CORPORATION, AND GENERAL ELECTRIC COMPANY Docket No. C-4710. Order, January 31, 2022 Letter Order granting Sartorius Stedium Biotech S.A.’s petition to acquire Novasep Process SaS’s chromatography equipment business.
LETTER ORDER APPROVING ACQUISITION Fiona Schaeffer, Esquire Milbank Rebecca Farrington, Esquire White & Case LLP Re: In the Matter of Danaher Corp.
Docket No. C-4710 Dear Ms. Schaefer and Ms. Farrington:
This letter responds to the Petition for Prior Approval of Sartorius Stedium Biotech S.A.’s Proposed Acquisition of Novasep Process SaS’s Chromotography Equipment Business (“Petition”), filed on October 28, 2021. The Petition requests that the Federal Trade Commission approve, pursuant to Paragraph X of the Order in this matter, Sartorius’s proposed acquisition of Novasep’s chromatography equipment business. The Petition was placed on the public record for comments until December 20, 2021, and no comments were received. After consideration of the Petition and other available information, the Commission has determined to approve the proposed acquisition. In according its approval, the Commission has relied upon the information submitted and the representations made in connection with the Petition, and has assumed them accurate and complete. By direction of the Commission.
VOLUME 173 Interlocutory Orders, Etc.